EXPLORING LULICONAZOLE AS A POTENT ANTIFUNGAL AGENT: MOLECULAR DOCKING FOR INTERACTION STUDIES IN THE DEVELOPMENT OF FORMULATION Authors: Saish P And Ashwin K*
ABSTRACT
Continuous efforts are being made in pharmaceutical research to enhance the effectiveness of
existing medications through the research and development of new drug delivery systems
(DDS). Recent advancements in high-throughput screening have led to the development of
lipophilic Active Pharmaceutical Ingredients (APIs). An example of a topical broad-spectrum
antifungal agent is Luliconazole. Because of its poor water solubility, topical administration is
limited, and topical absorption is restricted. The solubility of the drug in the stratum corneum's
lipid phase also acts as a rate-limiting stage in penetration. Fungal infections impact the
epidermis, dermis, and deeper layers of skin, necessitating treatment delivery tailored to target
high drug concentrations at the epidermis and dermis layers. The present study involves
interaction between the ideal candidates to optimize the Nano emulation. Interaction based on
Docking provides Ricinoleic acid, a measured component of Caster oil, in addition to tween
80 and ethanol. The present study involves molecular docking studies that revealed an
interesting binding profile.
Keywords: Drug delivery system, Antifungal, Docking, Nano-emulsion Publication date: 01/04/2025 https://ijbpas.com/pdf/2025/April/MS_IJBPAS_2025_8930.pdfDownload PDFhttps://doi.org/10.31032/IJBPAS/2025/14.4.8930